Boston Partners
GRDN

Boston Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Boston Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8M Sell
983,868
-33,815
-3% -$1.31M 0.04% 304
2026
Q1 		$38.4M Sell
1,017,683
-36,953
-4% -$1.21M 0.04% 287
2025
Q4 		$32M Buy
1,054,636
+7,759
+0.7% +$220K 0.03% 318
2025
Q3 		$26.9M Buy
1,046,877
+845,048
+419% +$20.1M 0.03% 339
2025
Q2 		$4.23M Buy
+201,829
New +$4.55M ﹤0.01% 460

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Boston Partners's GRDN Position: Q2 2026 in Review

Boston Partners reduced its Guardian Pharmacy Services (GRDN) stake by 3.3% in Q2 2026, selling an estimated $1.31M and leaving 983,868 shares worth $40.8M. The position accounts for 0.04% of the portfolio, ranked #304.

Boston Partners first reported a position in GRDN in Q2 2025 and has held it in 5 quarters since. 189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Boston Partners held 983,868 shares of Guardian Pharmacy Services worth $40.8M as of Q2 2026.
  • Boston Partners sold 33,815 Guardian Pharmacy Services shares in Q2 2026, an estimated $1.31M.
  • Guardian Pharmacy Services made up 0.04% of Boston Partners's portfolio in Q2 2026, its #304 holding.
  • Boston Partners first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 5 quarters since.
  • 189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.